MD2850F1 - Metoda de inducere a avortului medicamentos - Google Patents

Metoda de inducere a avortului medicamentos

Info

Publication number
MD2850F1
MD2850F1 MDA20050046A MD20050046A MD2850F1 MD 2850 F1 MD2850 F1 MD 2850F1 MD A20050046 A MDA20050046 A MD A20050046A MD 20050046 A MD20050046 A MD 20050046A MD 2850 F1 MD2850 F1 MD 2850F1
Authority
MD
Moldova
Prior art keywords
medicamental
abortion
inducing
hours
izoturon
Prior art date
Application number
MDA20050046A
Other languages
English (en)
Other versions
MD2850G2 (ro
Inventor
Valentin FRIPTU
Victor GHICAVII
Ludmila FRIPTU
Mihail Todiras
Ecaterina Stratu
Corina Cardaniuc
Original Assignee
Valentin FRIPTU
Victor GHICAVII
Ludmila FRIPTU
Mihail Todiras
Ecaterina Stratu
Corina Cardaniuc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valentin FRIPTU, Victor GHICAVII, Ludmila FRIPTU, Mihail Todiras, Ecaterina Stratu, Corina Cardaniuc filed Critical Valentin FRIPTU
Priority to MDA20050046A priority Critical patent/MD2850G2/ro
Publication of MD2850F1 publication Critical patent/MD2850F1/ro
Publication of MD2850G2 publication Critical patent/MD2850G2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Inventia se refera la medicina, in special la obstetrica si ginecologie si poate fi utilizata pentru intreruperea sarcinii la termene mici si anume pana la 56 zile, asociate cu amenoree. Esenta inventiei consta in aceea ca se administreaza per os 200 mg de mifepriston, apoi, peste 24...48 de ore, se administreaza de patru ori intravaginal peste fiecare 6 ore cate un supozitor, care contine 50 mg de bromura de S-etilizotiouroniu (izoturon).
MDA20050046A 2005-02-18 2005-02-18 Metodă de inducere a avortului medicamentos MD2850G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050046A MD2850G2 (ro) 2005-02-18 2005-02-18 Metodă de inducere a avortului medicamentos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050046A MD2850G2 (ro) 2005-02-18 2005-02-18 Metodă de inducere a avortului medicamentos

Publications (2)

Publication Number Publication Date
MD2850F1 true MD2850F1 (ro) 2005-09-30
MD2850G2 MD2850G2 (ro) 2006-07-31

Family

ID=35057541

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050046A MD2850G2 (ro) 2005-02-18 2005-02-18 Metodă de inducere a avortului medicamentos

Country Status (1)

Country Link
MD (1) MD2850G2 (ro)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20070283A (ro) * 2007-10-16 2009-07-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Procedeu de formare a curentului de încărcare pentru un acumulator de energie capacitiv
MD215Z (ro) * 2007-10-16 2010-12-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Dispozitiv de încărcare a acumulatorului capacitiv
MD281Z (ro) * 2009-10-23 2011-04-30 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Convertor de tensiune cu rezonanţă reglabil
MD4073C1 (ro) * 2008-11-06 2011-05-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Convertizor stabilizat de tensiune înaltă

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263C2 (ro) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ Remediu cu acţiune antihipotensivă "IZOTURON"
MD1223C2 (ro) * 1997-07-15 2000-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Aplicarea dimetilfosfatului de S-metil-izo-tiouroniu în calitate de substanţă vasoconstrictoare şi preparat farmaceutic pe baza lui
MD1431G2 (ro) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Remedii antihipotensive
MD2228G2 (ro) * 2003-01-21 2004-02-29 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Utilizarea derivaţiilor izotiouronici în tratamentul şi profilaxia atoniei intestinale
MD2323G2 (ro) * 2003-06-23 2004-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Utilizarea bromurii de S-etilizotiouroniu (izoturon) în calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin
MD2491G2 (ro) * 2004-02-10 2005-01-31 Виктор ГИКАВЫЙ Utilizarea bromurii de S-etilizotiouroniu (izoturonului) pentru tratamentul algodismenoreii

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20070283A (ro) * 2007-10-16 2009-07-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Procedeu de formare a curentului de încărcare pentru un acumulator de energie capacitiv
MD215Z (ro) * 2007-10-16 2010-12-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Dispozitiv de încărcare a acumulatorului capacitiv
MD4073C1 (ro) * 2008-11-06 2011-05-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Convertizor stabilizat de tensiune înaltă
MD281Z (ro) * 2009-10-23 2011-04-30 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Convertor de tensiune cu rezonanţă reglabil

Also Published As

Publication number Publication date
MD2850G2 (ro) 2006-07-31

Similar Documents

Publication Publication Date Title
AR109461A2 (es) Formulación de anticuerpo anti-cd20 y su uso para preparar un medicamento
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
PL356846A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
BRPI0517799A (pt) composição para facilitar o parto humano
AR053651A1 (es) Tratamiento combinado de anticuerpo antictla4 r inhibidor de aromatasa para el cancer de mama
HUP0303720A2 (hu) Egy immunstimuláns oligonukleotidot és egy tokolt tartalmazó adjuvánskészítmény
BRPI0622298A8 (pt) Oligorribonucleotídeo para estimular a produção de uma citocina pró-inflamatória, uso do mesmo e composição contendo tal oligorribonucleotídeo
MD2850F1 (ro) Metoda de inducere a avortului medicamentos
CA2468748A1 (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
PE20091693A1 (es) Antagonista del receptor 2 activado con proteasa
HUP0203844A2 (hu) Növekedési hormon kibocsátó tulajdonságú vegyület, ezt tartalmazó gyógyszerkészítmény és alkalmazása
SE0300098D0 (sv) Use of cyclin D1 inhibitors
BR0008076A (pt) 16-hidroxiestratrienos como estrogênios de efeito seletivo
MA27474A1 (fr) Vaccin
TW200621312A (en) Oral solid dosage forms containing a low dose of estradiol
HUP0401634A2 (hu) LHRH-antagonisták használata kasztrációt nem okozó dózisokban a T-sejtes immunitás javítására és gyógyszerkészítmények előállítására
FR3076711B1 (fr) Composition comprenant l'hydroxychloroquine et utilisation therapeutique
MD2323F1 (ro) Utilizarea bromurii de S-etilizotiouroniu (izoturon) in calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine in cazul miomului uterin
MD2053B1 (ro) Remediu cu actiune interferonogena
MD2733F1 (ro) Metoda de tratament al dereglarilor ciclului menstrual asociate cu hepatite virale cronice
Doherty et al. Couples, sexual networks, populations: implications for use of coitus interruptus
ATE470669T1 (de) D-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpregn 4-ene-20-yne-3-one in form des reinen 3e- und 3z- oximes sowie das verfahren zur herstellung der mischung der isomere wie auch der reinen isomere
Bernitz et al. Corrigendum to" Detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer) using QuantiFERON®-TB Gold (QFT) tubes and the Qiagen cattletype® IFN-gamma ELISA"[J. Vet. Immunol. Immunopathol. 196 (2018) 48-52]
DK1150683T3 (da) Anvendelse af dienogest i højere dosering

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees